Shares of enVVeno Medical Corp. plunged as much as 79% on Aug. 21 after it received bad news from the Food and Drug Administration.The Irvine-based medical device maker on Aug. 20 announced that the ...
PM ET IRVINE, CA / ACCESS Newswire / August 15, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of deep venous ...
enVVeno Medical Corporation, a company setting new standards of care for the treatment of venous disease, announced today that it has successfully completed its rebranding and that its shares are ...
About enVVeno Medical Corp. enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for ...
enVVeno Medical Corporation (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions ...
enVVeno Medical Corporation (NASDAQ:NVNO) (”enVVeno” or the “Company”), a company setting new standards of care for the treatment of venous disease, today announced the pricing of an ...
enVVeno expects to receive aggregate gross proceeds from the offering, excluding the exercise of the underwriter's option, if any, of approximately $15.0 million, excluding underwriting discounts ...
enVVeno Medical Corp 競合他社・同業他社分析 - Industrial Applications and Services セクター
VAR_0__セクターの同業他社および競合他社に対するenVVeno Medical Corpの比較分析、AIを活用した予測および主要財務指標を掲載。
Our AI model demonstrates 2% historical accuracy for NVNO predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
VAR_0__株価予測に影響を与える要因は何か?
当社の分析では、enVVeno Medical Corpの財務指標、Industrial Applications and Servicesセクターの動向、市場センチメント、テクニカル指標、業績データ、株価に影響を与えるマクロ経済要因を考慮しています。
2025年、enVVeno Medical Corpは良い投資先か?
AIの分析によると、enVVeno Medical Corpは次のようになる。 さまざまな市場シナリオの可能性. 投資の意思決定を行う前に、リスク許容度、投資スケジュール、ポートフォリオの分散を考慮してください。